This week in health IT: Focus on federal mandates

Two of the biggest federal mandates facing providers this year were in the news this week—for good and bad reasons.

More than $19 billion has been paid out in Meaningful Use incentives to more than 440,000 providers. Approximately 88 percent of all eligible hospitals have received an EHR incentive payment so far, reported Robert Anthony, deputy director of the Centers for Medicare & Medicaid Services (CMS) Office of E-Health Standards and Services at the latest Health IT Policy Committee meeting.

And, as of Dec. 31, 2013, nearly 9 out of 10 eligible hospitals have made a financial commitment to an EHR. CMS also released the results of a 2013 National Electronic Health Records Survey, which revealed that of the physicians who intend to participate in the Meaningful Use program, 19 percent had adopted all 14 of the 17 Stage 2 Core objectives.

EHR adoption has been continually touted as the infrastructure needed to improve the quality and efficiency of healthcare so these rates are encouraging.

On the other end of the spectrum, however, less than 10 percent of physician practices reported that they had made significant progress when rating their overall readiness for ICD-10 implementation. This is only a slight improvement from a June 2013 survey in which 4.7 percent said they had made significant progress.

In releasing the survey results, the Medical Group Management Association urged CMS to immediately take action to help ensure that physician practices can successfully undertake such a massive transition.

Do you think CMS should be doing more to help providers facilitate ICD-10 testing and preparation? Please share your thoughts.

Beth Walsh

Clinical Innovation + Technology editor

 

Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.